Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  News  >  Companies  >  All News

News : Companies
Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance ProfessionalsCalendarSectors

Research and Markets: Vaccine Market to 2019 - The Market is Expected to Reach $57.8 Billion by 2019 from $33.1 Billion in 2014

share with twitter share with LinkedIn share with facebook
share via e-mail
0
08/14/2015 | 10:50am EST

Research and Markets (http://www.researchandmarkets.com/research/mcbchq/vaccine_market_by) has announced the addition of the "Vaccine Market by Technology, Type, End User, Disease Indication - Forecasts to 2019" report to their offering.

Vaccine Market by Technology (Live Attenuated, Toxoid, Conjugate, Subunit, Synthetic, Dendritic Cell, Inactivated), Type (Preventive, Therapeutic), End User (Pediatrics, Adults), Disease Indication (Infectious Disease, Cancer, Allergy) - Forecasts to 2019

The vaccines market is expected to reach $57,885.4 million by 2019 from $33,140.6 million in 2014, at a CAGR of 11.8%. For the purposes of this report the global vaccines market is categorized on the basis of type, technology, disease indication, end user, and geography. The preventive vaccines segment is expected to register the highest growth rate in the vaccines market, by type, during the forecast period. Its favorable growth is attributed to the rising prevalence of diseases and increasing number of government initiatives taken for immunization programs worldwide.

Major factors contributing to growth of the vaccines market include rising prevalence of diseases, increasing company investments in vaccine development, and rising initiatives by non-government organizations for vaccinations. Furthermore, government support in the form of funding is another major factor providing impetus for growth of this market. For instance, in November 2014, the U.K. government granted $2 billion (£1.32 billion) to GAVI for the improvement of immunization programs in poor countries.

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights

5 Market Overview

6 Industry Insights

7 Vaccines Market, By Technology

8 Vaccines Market, By Type

9 Vaccines Market, By Disease Indication

10 Vaccines Market, By End User

11 Global Vaccine Technology Market, By Region

12 Competitive Landscape

13 Company Profiles

14 Appendix

Companies Mentioned

  • Bavarian Nordic
  • CSL Limited
  • Emergent Biosolutions, Inc.
  • Glaxosmithkline, PLC.
  • Johnson & Johnson
  • Medimmune, LLC. (A Subsidiary of Astrazeneca)
  • Merck & Co., Inc.
  • Novartis AG
  • Pfizer, Inc.
  • SANOFI

For more information visit http://www.researchandmarkets.com/research/mcbchq/vaccine_market_by


© Business Wire 2015
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news "Companies"
09:35aSCHNEIDER ELECTRIC : works with Canalys to survey resellers around the opportunities and challenges customers are facing around edge computing
AQ
09:35aCORNERSTONE ONDEMAND : Joins Forces with Facebook to Enhance the Value of Virtual Reality Training at Work; New Oculus integration helps capture the impact VR training has on employees and the new SDK will encourage the broader adoption of enterprise VR training content
AQ
09:35aWEB SUMMIT 2019 : Schneider Electric drives event's sustainability
AQ
09:35aPURA – Puration Announces Latin American LOI To Pursue $9 Billion Cannabis Market
GL
09:35aProPhase Labs Reports Financial Results for the Three Months and Nine Months Ended September 30, 2019
GL
09:35aAncilia, Inc. Wins “Best in Show” at New York City 1st Pitch Life Science Competition
GL
09:34aWAITR HOLDINGS INC. : Regulation FD Disclosure (form 8-K)
AQ
09:34aOVERSTOCK : 3Q Earnings Snapshot
AQ
09:34aNutraLife Biosciences Inc., Through Its Wholly Owned Subsidiary PhytoChem Technologies, is Pleased to Announce an Update of its 2019 Wisconsin PCR Hemp Harvest
GL
09:33aGENEREX BIOTECHNOLOGY : Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)
AQ
Latest news "Companies"